A histone methyltransferase inhibitor can reverse epigenetically acquired drug resistance in the malaria parasite Plasmodium falciparum Chan A, et al. bioRxiv, Sep 19, 2019.

Main|Search|PHGKB




Last Posted: Sep 26, 2019

---

• A histone methyltransferase inhibitor can reverse epigenetically acquired drug resistance in the malaria parasite Plasmodium falciparum
  Chan A, et al. bioRxiv, Sep 19, 2019.
• Rare mutations in Pfmdr1 gene of Plasmodium falciparum detected in clinical isolates from patients treated with anti-malarial drug in Nigeria.
  Idowu Abel O et al. Malaria journal 2019 Sep (1) 319
• Deep Learning for Smartphone-based Malaria Parasite Detection in Thick Blood Smears.
  Yang Feng et al. IEEE journal of biomedical and health informatics 2019 Sep
• Targeted Next Generation Sequencing for malaria research in Africa: current status and outlook.
  Ghansah Anita et al. Malaria journal 2019 Sep (1) 324
• You (don’t) give me fever
  PM Brunner, Sci Trans Med, September 18, 2018
• Multidrug-Resistant Malaria Expands its Reach
  B Kuehn, JAMA, September 17, 2019
• Sequencing for malaria diversity
  DJ Burgess, Nat Rev Genetics, September 16, 2019
• Deployment and utilization of next-generation sequencing of Plasmodium falciparum to guide anti-malarial drug policy decisions in sub-Saharan Africa: opportunities and challenges.
  Ishengoma Deus S et al. Malaria journal 2019 Sep (1) 267
• The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremia.
  Muriuki John Muthii et al. Science advances 2019 Sep (9) eaaw0109
• An improved nucleic acid extraction method from dried blood spots for amplification of Plasmodium falciparum kelch13 for detection of artemisinin resistance.
  Zainabadi Kayvan et al. Malaria journal 2019 Jun (1) 192

more